As of Mar 16
| +0.0088 / +1.35%|
The 4 analysts offering 12-month price forecasts for Intellipharmaceutics International Inc have a median target of 2.75, with a high estimate of 3.10 and a low estimate of 1.63. The median estimate represents a +317.36% increase from the last price of 0.66.
The current consensus among 4 polled investment analysts is to Buy stock in Intellipharmaceutics International Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.